We are excited to participate in the Labroots Drug Discovery & Development Virtual Event Series, scheduled for February 21, 2024.
Martin Shaw, Business Development at AroCell, will deliver a presentation on the Thymidine Kinase 1 immunoassay, highlighting its significance as a valuable translational biomarker from drug discovery through to clinical trials. You can view the presentation on February 21 by following this link: https://bit.ly/drugdiscovery2024